This chapter highlights the role of imaging, particularly magnetic resonance imaging (MRI) and fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT), as a “compass” along the therapeutic path in patients with malignant diseases of the uterus.
Copyright 2018, The Author(s).